|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 5/074 | |
| G01N 33/483 | |||
| A61K 35/28 |
| (11) | Number of the document | 2568991 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11781272.7 |
| Date of filing the European patent application | 2011-05-12 | |
| (97) | Date of publication of the European application | 2013-03-20 |
| (45) | Date of publication and mention of the grant of the patent | 2018-03-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/036235 |
| Date | 2011-05-12 |
| (87) | Number | WO 2011/143415 |
| Date | 2011-11-17 |
| (30) | Number | Date | Country code |
| 440617 P | 2011-02-08 | US | |
| 334001 P | 2010-05-12 | US |
| (72) |
MAYS, Robert, W., US
|
| (73) |
ABT Holding Company,
3201 Carnegie Avenue, Cleveland, OH 44115,
US
|
| (54) | MODULATION OF SPLENOCYTES IN CELL THERAPY |
| MODULATION OF SPLENOCYTES IN CELL THERAPY |